414
Participants
Start Date
January 4, 2011
Primary Completion Date
July 22, 2016
Study Completion Date
July 22, 2016
Guadecitabine
Subcutaneous injection
Cornell University, New York
Columbia University Medical Center, New York
Roswell Park Cancer Institute, Buffalo
Temple University, Philadelphia
Duke University, Durham
Florida Cancer Specialists - North, St. Petersburg
Florida Cancer Specialists - South, Fort Myers
Sarah Cannon Research Institute, Nashville
Tennessee Oncology, Nashville
Ohio State University, Columbus
University of Chicago Cancer Center, Chicago
MD Anderson Cancer Center, Houston
Mayo Clinic, Scottsdale
University of Southern California, Los Angeles
Yale University, New Haven
Princess Margaret Hospital, Toronto
Lead Sponsor
Astex Pharmaceuticals, Inc.
INDUSTRY